GRIMAUD BRETT A. (SVP, GEN COUNSEL AND SECRETARY) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/22/2025ACC: 0001415889-25-014259
Officer· SVP, GEN COUNSEL AND SECRETARY
Since Feb 2026
-9.74K
Net shares
Net seller
$92.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.74K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−9.74K
Price / share
$9.45
Trade value
$92.07K
% of position
2.5%
5/20/2025
393.81K→384.07K
Total
Net shares
−9.74K
Net value
-$92.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 5/20/2025 | F · Tax Withholding | −9.74K | $9.45 | $92.07K | 2.5% | 393.81K | 384.07K |
| Total | −9.74K | -$92.07K | ||||||
Derivative Transactions0
No derivative transactions reported